Catheter Precision Stock Today
VTAK Stock | 0.46 0.01 2.13% |
Performance0 of 100
| Odds Of DistressOver 85
|
Catheter Precision is selling for 0.46 as of the 18th of January 2025. This is a 2.13% down since the beginning of the trading day. The stock's last reported lowest price was 0.44. Catheter Precision has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 24th of January 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of September 2018 | Category Healthcare | Classification Health Care |
Catheter Precision is entity of United States. It is traded as Stock on NYSE MKT exchange. The company has 8 M outstanding shares of which 183.68 K shares are at this time shorted by private and institutional investors with about 0.02 trading days to cover. More on Catheter Precision
Moving against Catheter Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Catheter Stock Highlights
CEO Chairman | David Jenkins | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Catheter Precision can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Catheter Precision's financial leverage. It provides some insight into what part of Catheter Precision's total assets is financed by creditors.
|
Catheter Precision (VTAK) is traded on NYSE MKT Exchange in USA. It is located in 1670 Highway 160 West, Fort Mill, SC, United States, 29708 and employs 14 people. Catheter Precision is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.76 M. Catheter Precision conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 8 M outstanding shares of which 183.68 K shares are at this time shorted by private and institutional investors with about 0.02 trading days to cover.
Catheter Precision generates negative cash flow from operations
Check Catheter Precision Probability Of Bankruptcy
Ownership AllocationCatheter Precision shows 13.52 percent of its outstanding shares held by insiders and 4.66 percent owned by other corporate entities.
Check Catheter Ownership Details
Catheter Precision Historical Income Statement
Catheter Stock Against Markets
Catheter Precision Corporate Management
Patricia Kennedy | Chief Officer | Profile | |
Missiaen Huck | Chief Officer | Profile | |
Margrit CPA | Interim Secretary | Profile | |
MarieClaude Jacques | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 30.61 | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.